Holen Sie sich die Stockscreener-App
0.4631
4.40%
0.0195
Handel nachbörslich:
.48
0.0169
+3.65%
Werewolf Therapeutics Inc Aktie (HOWL) Neueste Nachrichten
HOWL Q1 2026 Earnings: Narrowed Loss Exceeds Estimates, Stock RisesProfit Announcement - Newser
HOWL Stock Chart | WEREWOLF THERAPEUTICS INC (NASDAQ:HOWL) - ChartMill
Werewolf Therapeutics (HOWL) Stock Price, News & Analysis - MarketBeat
Werewolf Therapeutics director Luke Evnin sells $76,363 in stock By Investing.com - Investing.com Canada
Werewolf Therapeutics director Luke Evnin sells $76,363 in stock - Investing.com
Evnin-linked funds sell 171K Werewolf Therapeutics (HOWL) shares - Stock Titan
[144] Werewolf Therapeutics, Inc. SEC Filing - Stock Titan
Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives - Stocktwits
Werewolf Therapeutics (HOWL) Stock: Down -3.84%, Support Test at $0.47 2026-05-18ATR Levels - newser.com
Werewolf Therapeutics (HOWL) price target increased by 12.00% to 7.14 - MSN
Werewolf Therapeutics (HOWL) price target increased by 20.19% to 6.38 - MSN
Should You Sell Werewolf Therapeutics (HOWL) After -5.07% Drop? 2026-05-17Head and Shoulders - Newser
Werewolf Therapeutics (HOWL) Reports Strong Q4 2025 — Revenue $N/A, EPS BeatsCommunity Watchlist - Newser
RA Capital funds sell HOWL shares, report 12.6% Werewolf Therapeutics stake - Stock Titan
News | Struggling Boston biotech firm cuts ties with headquarters space - CoStar
Werewolf Therapeutics Insider Sold Shares Worth $280,210, According to a Recent SEC Filing - Moomoo
Here's Why We're A Bit Worried About Werewolf Therapeutics' (NASDAQ:HOWL) Cash Burn Situation - Yahoo Finance
HOWL Director Luke Evnin Sells 44,679 Shares on May 13, 2026 - Meyka
Werewolf Therapeutics director Luke Evnin sells $24,126 in stock - Investing.com UK
Werewolf Therapeutics director Luke Evnin sells $24,126 in stock By Investing.com - Investing.com Australia
Evnin-linked funds sell 44,679 Werewolf (NASDAQ: HOWL) shares under plan - Stock Titan
Werewolf Therapeutics vacates Watertown headquarters as cash dwindles - The Business Journals
TradingKey - TradingKey
Werewolf Therapeutics director Luke Evnin sells $280,210 in company stock By Investing.com - Investing.com South Africa
Werewolf Therapeutics director Luke Evnin sells $280,210 in company stock - Investing.com India
MPM group cuts Werewolf Therapeutics (HOWL) holdings in May stock sales - Stock Titan
Director-linked MPM funds trim Werewolf Therapeutics (HOWL) stake under 10b5-1 plan - Stock Titan
Ra capital, Peter Kolchinsky sell $390k Werewolf Therapeutics shares - Investing.com India
Ra capital, Peter Kolchinsky sell $390k Werewolf Therapeutics shares By Investing.com - Investing.com South Africa
RA Capital funds trim Werewolf Therapeutics (NASDAQ: HOWL) stake with 565K-share sale - Stock Titan
HOWL SEC FilingsWerewolf Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
B of A Securities Maintains Werewolf Therapeutics (HOWL) Buy Recommendation - MSN
Werewolf sells JZP898 rights to Jazz, repays K2 debt amid review - Stock Titan
Werewolf Therapeutics (NASDAQ:HOWL) Meets Q1 Estimates, Clears Debt, and Advances Strategic Review - ChartMill
Werewolf Therapeutics director Luke Evnin sells $64,216 in shares - Investing.com UK
Werewolf Therapeutics director Luke Evnin sells $64,216 in shares By Investing.com - Investing.com Nigeria
Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates - Investing News Network
Funds tied to Werewolf Therapeutics (HOWL) director sell 100,581 shares - Stock Titan
Werewolf Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Strategic review, Jazz asset sale and Q1 loss at Werewolf Therapeutics (NASDAQ: HOWL) - Stock Titan
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):